Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Discoidin Domain Receptor Tyrosine Kinase 2 (DDR2) is a receptor tyrosine kinase activated by fibrillar collagens. It plays a critical role in cell growth, differentiation, migration, and extracellular matrix remodeling. Dysregulation of DDR2 is implicated in diseases such as fibrosis, arthritis, and various cancers.
DDR2 is activated upon binding to specific types of fibrillar collagens—primarily types I, III, and X—via its extracellular discoidin domain. This interaction triggers autophosphorylation within the cytoplasmic kinase domain and initiates downstream signaling cascades that regulate cell behavior and ECM remodeling. Inhibition of DDR2 kinase activity or collagen binding is a potential therapeutic strategy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Discoidin Domain Receptor Tyrosine Kinase 2 (DDR2).